View Older Stories View More Recent Stories

Apr 27, 2026 04:01PM Janux Therapeutics discontinues EGFR cancer drug development
Apr 22, 2026 06:42AM H.C. Wainwright Reiterates Buy Rating on Janux Therapeutics (JANX)
Apr 20, 2026 04:06AM Barclays Double Downgrades Janux Therapeutics (JANX) to Underweight
Apr 15, 2026 02:24AM UBS Downgrades Janux Therapeutics (JANX) to Neutral
Apr 1, 2026 08:02AM Janux receives $35 million milestone payment from Bristol Myers Squibb
Mar 3, 2026 09:20AM Janux Therapeutics (JANX) PT Lowered to $80 at Truist Securities
Feb 26, 2026 05:20PM Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c
Jan 20, 2026 05:14AM Clear Street Downgrades Janux Therapeutics (JANX) to Hold
Dec 2, 2025 09:25AM Truist on Janux Therapeutics (JANX): 'The Post-Market Selloff Appears Overblown'
Dec 2, 2025 07:40AM Janux Therapeutics (JANX) Reiterated at Buy by UBS After JANX007 Ph1 update
Dec 2, 2025 07:29AM Janux Therapeutics (JANX) PT Lowered to $150 at Cantor Fitzgerald
Dec 2, 2025 06:40AM Janux Therapeutics (JANX) PT Lowered to $45 at H.C. Wainwright
Dec 2, 2025 05:28AM Janux Therapeutics (JANX) PT Lowered to $49 at BofA Securities
Dec 2, 2025 04:28AM Janux Therapeutics (JANX) PT Lowered to $38 at Stifel
Dec 1, 2025 04:32PM After-hours movers: MongoDB, Instacart, Iris Energy, Credo Technology and more
Nov 17, 2025 04:13PM Wolfe Research Starts Janux Therapeutics (JANX) at Peerperform
Nov 11, 2025 01:40PM Janux Therapeutics (JANX) PT Lowered to $65 at Jones Trading
Nov 6, 2025 06:28PM Janux Therapeutics, Inc. (JANX) Tops Q3 EPS by 23c
Oct 4, 2025 04:00PM Why UBS says Q4 is eventful for SMID oncology stocks
Sep 17, 2025 04:34AM Barclays Starts Janux Therapeutics (JANX) at Overweight
Sep 10, 2025 06:10AM Truist Securities Starts Janux Therapeutics (JANX) at Buy
Sep 10, 2025 02:00AM Stifel Resumes Janux Therapeutics (JANX) at Buy
Sep 4, 2025 05:43AM Guggenheim Starts Janux Therapeutics (JANX) at Buy
Aug 19, 2025 06:15AM Piper Sandler Starts Janux Therapeutics (JANX) at Overweight
Jul 25, 2025 07:39AM Cantor Fitzgerald Reiterates Overweight Rating on Janux Therapeutics (JANX)
Jul 11, 2025 06:24AM Raymond James Starts Janux Therapeutics (JANX) at Outperform
May 28, 2025 04:25AM Citizens JMP shares updates on cancer treatment stocks
May 12, 2025 06:19AM Janux Therapeutics (JANX) PT Lowered to $89 at Leerink Partners
May 9, 2025 04:39PM Janux Therapeutics, Inc. (JANX) Misses Q1 EPS by 1c
May 5, 2025 08:31AM Janux Therapeutics (JANX) initiates expansion Phase 1b studies for JANX007
Feb 28, 2025 07:34AM Cantor Fitzgerald Reiterates Overweight Rating on Janux Therapeutics (JANX)
Jan 24, 2025 04:02PM Janux Therapeutics (JANX) Appoints Zachariah McIver as Chief Medical Officer
Jan 10, 2025 06:09AM BTIG Reiterates Buy Rating on Janux Therapeutics (JANX)
Dec 12, 2024 01:17PM Clear Street Starts Janux Therapeutics (JANX) at Buy
Dec 5, 2024 06:05AM Janux Therapeutics (JANX) Prices 5.32M Share Offering at $63/sh
Dec 4, 2024 07:13AM Janux Therapeutics (JANX) PT Raised to $62 at Scotiabank
Dec 3, 2024 04:02PM Janux Therapeutics (JANX) Announces Proposed $300M Share Offering
Dec 3, 2024 12:25PM Janux Therapeutics (JANX) PT Raised to $105 at Jones Trading
Dec 3, 2024 08:50AM TD Cowen Reiterates Buy on Janux Therapeutics (JANX) as JANX007 'Far Exceeds High Expectations'
Dec 3, 2024 08:22AM Janux Therapeutics (JANX) PT Raised to $115 at Stifel
Dec 3, 2024 07:06AM William Blair on Janux Therapeutics (JANX): 'Exceeding Investor Expectations and Raising the Bar in mCRPC'
Dec 3, 2024 06:55AM Janux Therapeutics (JANX) PT Raised to $91 at Leerink Partners
Dec 3, 2024 06:45AM Janux Therapeutics (JANX) PT Raised to $70 at H.C. Wainwright
Dec 3, 2024 06:32AM Janux Therapeutics (JANX) PT Raised to $200 at Cantor Fitzgerald, 'Mic Drop - '007 HRPC Update Waaayyy Above Expectations'
Dec 3, 2024 05:30AM Janux Therapeutics (JANX) call put ratio 1 call to 2.8 puts into data
Dec 3, 2024 05:27AM Stifel Reiterates Buy Rating on Janux Therapeutics (JANX)
Dec 3, 2024 05:26AM Janux Therapeutics (JANX) PT Raised to $100 at BTIG, 'The World Is Not Enough — 007 Strikes Again Exceeding The Street's Highest Expectations'
Dec 2, 2024 04:41PM Vir Biotechnology (VIR) Trades Higher in Sympathy with Janux Therapeutics (JANX)
Dec 2, 2024 04:40PM Janux Therapeutics (JANX) Surges 40% After Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC
Dec 2, 2024 04:38PM After-hours movers: Zscaler, Honeywell, Microchip Technology and more
View More Recent Stories View Older Stories